Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Knight

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|December 1, 1977
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancerW A Knight, R B Livingston, E J Gregory, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy for stage II, estrogen receptor negative breast cancerW A Knight, G M Clark, C K Osborne, et al.
Cancer|December 15, 1980
The value of estrogen and progesterone receptors in the treatment of breast cancerC K Osborne, M G Yochmowitz, W A Knight, et al.
Investigational New Drugs|January 1, 1983
Pharmacokinetics of high dose melphalanM R Hersh, T M Ludden, J G Kuhn, et al.
The American Journal of Physiology|August 1, 1982
Steroid hormone receptors and carcinoma of the breastW L McGuire, C K Osborne, G M Clark, et al.
Transfusion|November 1, 1986
A comparison of frozen and fresh platelet concentrates in the support of thrombocytopenic patientsB L Towell, S P Levine, W A Knight, et al.
Blood|November 1, 1980
Modern approaches to the treatment of breast cancerC K Osborne, W A Knight, M G Yochmowitz, et al.
Annals of Clinical Research|October 1, 1980
Steroid hormone receptors in the management of human breast cancerW A Knight, C K Osborne, M G Yochmowitz, et al.
Cancer Clinical Trials|January 1, 1981
Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot studyJ W Myers, W A Knight, R B Livingston, et al.
Cancer Treatment Reports|December 1, 1982
Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D M Loesch, L P Leichman, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|December 1, 1977
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancerW A Knight, R B Livingston, E J Gregory, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant therapy for stage II, estrogen receptor negative breast cancerW A Knight, G M Clark, C K Osborne, et al.
Cancer|December 15, 1980
The value of estrogen and progesterone receptors in the treatment of breast cancerC K Osborne, M G Yochmowitz, W A Knight, et al.
Investigational New Drugs|January 1, 1983
Pharmacokinetics of high dose melphalanM R Hersh, T M Ludden, J G Kuhn, et al.
The American Journal of Physiology|August 1, 1982
Steroid hormone receptors and carcinoma of the breastW L McGuire, C K Osborne, G M Clark, et al.
Transfusion|November 1, 1986
A comparison of frozen and fresh platelet concentrates in the support of thrombocytopenic patientsB L Towell, S P Levine, W A Knight, et al.
Blood|November 1, 1980
Modern approaches to the treatment of breast cancerC K Osborne, W A Knight, M G Yochmowitz, et al.
Annals of Clinical Research|October 1, 1980
Steroid hormone receptors in the management of human breast cancerW A Knight, C K Osborne, M G Yochmowitz, et al.
Cancer Clinical Trials|January 1, 1981
Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot studyJ W Myers, W A Knight, R B Livingston, et al.
Cancer Treatment Reports|December 1, 1982
Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D M Loesch, L P Leichman, et al.
Pageof 5